Core Viewpoint - The International Association of Science Parks and Innovation Areas (IASP) World Conference will be held in Beijing from September 15 to 19, 2025, marking the fourth time this prestigious event has taken place in the city, and it will be the first time hosted under the name of the Beijing Municipal Government [1][2]. Group 1: Event Overview - The conference is expected to attract around 800 participants, including approximately 500 foreign guests from over 40 countries and regions, featuring leaders from renowned technology parks, enterprises, experts, government representatives, and investors [3]. - The agenda spans five days, with activities including technology visits to key sites in Beijing, such as the Zhongguancun International Robotics Industry Park and Shougang Park, aimed at fostering international cooperation [3][4]. Group 2: Participation and Contributions - China has 36 IASP member units, accounting for about 11% of the global total, making it the country with the most members in the IASP network, reflecting the robust development of China's technology parks [2]. - The conference will feature four high-level meetings and 15 parallel forums covering various topics, ensuring diverse perspectives and professional depth, with participation from experts across 27 countries [4][5]. Group 3: Innovations and Achievements - The conference will introduce the Changping Zhongguancun Life Science Park as a sub-venue, enhancing the exchange space and promoting deep integration of industry, academia, and research [5][6]. - The anticipated outcomes include the release of the International Technology Park Innovation Cooperation Initiative (Zhongguancun Initiative) and the Zhongguancun Index 2025, which will assess and showcase the innovation development of Beijing and Zhongguancun [6].

Market Overview - A-shares experienced a significant rebound on September 5, with the Shanghai Composite Index returning to 3,800 points and the ChiNext Index surging by 6.55%, marking a new high since January 2022 [1][2] - The total trading volume in the Shanghai and Shenzhen markets reached 2.3 trillion yuan, a decrease of 239.6 billion yuan compared to the previous trading day, with over 4,800 stocks rising and fewer than 500 declining [2] Sector Performance - The new energy sector saw a surge, particularly in solid-state battery stocks, with companies like Paton achieving a 30% limit-up and others like Jin Yinhe and Xian Dao Intelligent also hitting 20% limit-up [2] - The photovoltaic and wind power sectors were active, with Jinlang Technology gaining 20% and several other companies seeing increases of over 10% [3] - The sports sector also showed strength, with companies like Lisheng Sports hitting the limit-up, supported by government policies aimed at enhancing sports consumption and industry growth [4] Future Outlook - Multiple brokerage firms believe that the logic supporting the A-share market's rise remains unchanged, with reasonable market valuations and no signs of excessive speculation [1][5] - Analysts suggest that the market may continue a slow upward trend in September, with growth stocks likely to outperform, driven by new positive factors such as potential interest rate cuts by the Federal Reserve [6][5] - The overall market sentiment is expected to remain active, with continued support from capital flows and policy expectations, indicating an upward trend for A-shares [6][5]

Core Viewpoint - The company has decided to cancel previous financing guarantees for its subsidiary, Shandong Huasu, to optimize its financing structure and manage external guarantee limits effectively [9][12][40]. Group 1: Cancellation of Guarantees - The company approved the cancellation of a guarantee for Shandong Huasu's financing application to Qishang Bank, which was originally set at a limit of 10 million RMB for a one-year term [2][10]. - The company also approved the cancellation of a guarantee for Shandong Huasu's financing application to Hengfeng Bank, also set at a limit of 10 million RMB for a one-year term [3][11]. - The total amount of guarantees canceled amounts to 20 million RMB, which had not been implemented [12]. Group 2: Financing Lease Business - The company approved Shandong Huasu to engage in a sale-leaseback financing lease with Guoyao Ronghui, with a financing limit of up to 30 million RMB for a term not exceeding two years [4][15]. - The purpose of this financing is to supplement working capital and optimize the company's financing structure [22][34]. - The company and its subsidiaries will provide joint liability guarantees for this financing lease [16][25]. Group 3: External Guarantee Overview - After the cancellation of the guarantees, the total amount of external guarantees by the company and its subsidiaries is 931 million RMB, accounting for 58.61% of the latest audited net assets [12][36]. - The total balance of external guarantees is 471.87 million RMB, representing 29.71% of the latest audited net assets [12][36]. - The company has not experienced any overdue guarantees or legal disputes related to guarantees as of the announcement date [13][36].

第九届董事会 2025 年度第五次临时会议决议公告 共 3 页 证券代码：000931 证券简称：中关村 公告编号：2025-102 北京中关村科技发展（控股）股份有限公司 第九届董事会 2025 年度第五次临时会议决议公告 本公司及董事会全体成员保证信息披露内容的真实、准确和完整，没有虚假 记载、误导性陈述或重大遗漏。 北京中关村科技发展（控股）股份有限公司（以下简称：公司）第九届董事 会 2025 年度第五次临时会议通知于 2025 年 8 月 29 日以专人送达、电子邮件或 传真等方式发出，会议于 2025 年 9 月 5 日上午 10 时在北京市朝阳区霄云路 26 号鹏润大厦 B 座 22 层 1 号会议室以现场结合通讯表决方式如期召开。会议应到 董事 9 名，实到董事 9 名。会议召开程序符合相关法律法规和《公司章程》的有 关规定。经与会董事认真讨论研究，形成以下决议： 一、审议通过《关于取消公司为山东华素向齐商银行申请融资授信提供担保 的议案》； 表决结果：9 票同意，0 票反对，0 票弃权。 公司于 2024 年 7 月 12 日召开第八届董事会 2024 年度第八次临时会议，审 议通过公司全资 ...

（文章来源：证券日报） 证券日报网讯 9月5日晚间，中关村发布公告称，截至本公告披露日，公司及控股子公司未发生逾期担 保、涉及诉讼的担保及因担保被判决败诉而应承担损失的情况。 ...

Core Viewpoint - The stock of Zhongguancun (000931) has shown a slight increase, with a closing price of 5.32 yuan on September 5, 2025, reflecting a 0.76% rise, amidst mixed capital flows from different investor types [1] Group 1: Stock Performance and Capital Flow - On September 5, 2025, the stock recorded a trading volume of 101,100 hands and a transaction amount of 53.33 million yuan [1] - The net inflow of main funds was 3.63 million yuan, accounting for 6.8% of the total transaction amount, while retail investors experienced a net outflow of 3.25 million yuan, representing 6.1% of the total [1] - Over the past five days, the stock's closing prices fluctuated, with a peak of 5.35 yuan and a low of 5.21 yuan, indicating volatility in investor sentiment [2] Group 2: Financial Metrics and Industry Comparison - Zhongguancun's total market value is 4.007 billion yuan, significantly lower than the industry average of 16.321 billion yuan, ranking 114th out of 146 in the chemical pharmaceutical sector [3] - The company reported a net profit of 38.81 million yuan for the first half of 2025, a 6.65% increase year-on-year, despite a 2.71% decline in main revenue to 1.239 billion yuan [3] - The gross profit margin stands at 60.8%, which is higher than the industry average of 49.61%, indicating strong profitability relative to peers [3] Group 3: Business Segments - Zhongguancun operates in several business segments, including biopharmaceuticals, health products, elderly care services, and commercial concrete, with a focus on research, manufacturing, and sales of various pharmaceutical forms and medical devices [3]

Core Viewpoint - The company announced the cancellation of a guarantee for a financing credit application by Shandong Huasu to Qishang Bank during its board meeting on September 5 [2] Group 1 - The ninth board of the company held its fifth temporary meeting for the year 2025 [2] - Multiple resolutions were passed during the meeting, including the one regarding the cancellation of the guarantee [2]

Core Viewpoint - Zhongguancun Science and Technology Leasing (01601) has entered into a procurement agreement and a financing lease agreement for leasing assets valued at approximately RMB 20.1551 million and total lease payments of about RMB 20.3762 million [1] Group 1 - The company has signed a procurement agreement with Supplier II and Lessee II, Beijing Xingyou Zhongnuo Oil and Gas Technology, to purchase leasing assets valued at RMB 20.1551 million [1] - The financing lease agreement with Lessee II has a lease term of 36 months, with total lease payments amounting to approximately RMB 20.3762 million, which includes a principal of RMB 18.3 million and interest income (including VAT) of about RMB 2.0762 million [1] - The leased asset is an intelligent skidding unit for a star-spiral mixed transport gas pump, with a fair value of approximately RMB 20.1551 million [1]

Core Viewpoint - Zhongguancun Science and Technology Leasing (01601) has entered into a procurement agreement and a financing lease agreement for leasing assets valued at approximately RMB 20.1551 million, indicating a strategic move to enhance its asset portfolio and revenue generation through leasing activities [1] Group 1: Procurement Agreement - The company, as the buyer, has signed a procurement agreement with Supplier II and Lessee II for leasing asset XV, with a purchase price of RMB 20.1551 million [1] - The leased asset XV is identified as a star-shaped mixed transport vacuum pump intelligent unit, with a fair value of approximately RMB 20.1551 million [1] Group 2: Financing Lease Agreement - The company, acting as the lessor, has established a financing lease agreement with Lessee II for leasing asset XV, with a lease term of 36 months [1] - The total lease payments are approximately RMB 20.3762 million, which includes a principal amount of RMB 18.3 million and interest income (including VAT) of about RMB 2.0762 million [1]

证券代码：000931 证券简称：中关村 公告编号：2025-103 北京中关村科技发展（控股）股份有限公司 关于取消前期部分担保事项的公告 本公司及董事会全体成员保证信息披露内容的真实、准确和完整，没有虚假 记载、误导性陈述或重大遗漏。 关于取消前期部分担保事项的公告 共 3 页 北京中关村科技发展（控股）股份有限公司（以下简称：公司）于 2025 年 9 月 5 日召开第九届董事会 2025 年度第五次临时会议，审议通过《关于取消公 司为山东华素向齐商银行申请融资授信提供担保的议案》《关于取消公司为山东 华素向恒丰银行申请融资授信提供担保的议案》，具体情况如下： 一、担保情况概述 公司于 2024 年 7 月 12 日召开第八届董事会 2024 年度第八次临时会议，审 议通过公司全资子公司北京中关村四环医药开发有限责任公司（以下简称：四环 医药）之控股子公司北京华素制药股份有限公司（以下简称：北京华素）之全资 子公司山东华素制药有限公司（以下简称：山东华素）向齐商银行股份有限公司 小企业金融服务中心（以下简称：齐商银行）申请额度不超过 1,000 万元人民币 的融资授信，期限为 1 年，公司与四环医药共同 ...